Published in J Interferon Cytokine Res on February 15, 2013
The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J (2006) 4.10
Resistance to oral antiplatelet drugs--a Position Paper of the Working Group on antiplatelet drug resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society. Kardiol Pol (2008) 2.63
Reperfusion strategy in Europe: temporal trends in performance measures for reperfusion therapy in ST-elevation myocardial infarction. Eur Heart J (2010) 2.01
Effect of blood glucose levels on prognosis in acute myocardial infarction in patients with and without diabetes, undergoing percutaneous coronary intervention. Cardiol J (2008) 1.62
Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial. J Am Coll Cardiol (2004) 1.45
Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J (2010) 1.42
First-in-man study of paclitaxel-eluting stent BiOSS (Bifurcation Optimisation Stent System) dedicated for coronary bifurcation stenoses: three months results. Kardiol Pol (2012) 1.41
QT dynamics and the risk of sudden arrhythmic cardiac death in ischemic heart disease. Pacing Clin Electrophysiol (2004) 1.40
Safety and efficacy of a second-generation coronary sirolimus-eluting stent with biodegradable polymers in daily clinical practice: a 12-month follow-up of the ALEX registry. Coron Artery Dis (2016) 1.39
Aspirin 'resistance': impact on no-reflow, platelet and inflammatory biomarkers in diabetics after ST-segment elevation myocardial infarction. Cardiology (2015) 1.39
Causes of hospitalization and prognosis in patients with cardiovascular diseases. Secular trends in the years 2006-2014 according to the SILesian CARDiovascular (SILCARD) database. Pol Arch Med Wewn (2016) 1.38
Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J (2013) 1.29
Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty). JACC Cardiovasc Interv (2011) 1.13
Bioresorbable vascular scaffolds in patients with acute coronary syndromes: the POLAR ACS study. Pol Arch Med Wewn (2014) 1.11
The obesity paradox in acute coronary syndrome: a meta-analysis. Eur J Epidemiol (2014) 1.10
Not all fat is equal. J Am Coll Cardiol (2012) 1.09
Testing for antiphospholipid antibodies at autopsy. Forensic Sci Med Pathol (2014) 1.07
The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study. J Cachexia Sarcopenia Muscle (2010) 1.07
Bivalirudin: treatment effect versus side effect. Cardiovasc Ther (2014) 1.06
Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure. J Card Fail (2011) 1.03
Amiodarone-induced pulmonary toxicity. CMAJ (2012) 1.02
Red cell distribution width is associated with long-term prognosis in patients with stable coronary artery disease. BMC Cardiovasc Disord (2013) 1.01
Antiplatelet therapy and anticoagulants. Lancet (2013) 0.95
Circulating estradiol and mortality in men with systolic chronic heart failure. JAMA (2009) 0.95
Percutaneous closure of the left atrial appendage using the Amplatzer Cardiac Plug in patients with atrial fibrillation: evaluation of safety and feasibility. Kardiol Pol (2013) 0.95
Health related quality of life after percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with acute coronary syndromes without ST-segment elevation. 12-month follow up. Eur J Cardiothorac Surg (2005) 0.93
A comparison of ST elevation versus non-ST elevation myocardial infarction outcomes in a large registry database: are non-ST myocardial infarctions associated with worse long-term prognoses? Int J Cardiol (2010) 0.92
Effect of anemia in high-risk groups of patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol (2010) 0.89
The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively. Cardiovasc Diabetol (2012) 0.89
Comparison of five-year outcomes of patients with and without chronic total occlusion of noninfarct coronary artery after primary coronary intervention for ST-segment elevation acute myocardial infarction. Am J Cardiol (2011) 0.86
The influence of diabetes on in-hospital and long-term mortality in patients with myocardial infarction complicated by cardiogenic shock: results from the PL-ACS registry. Kardiol Pol (2012) 0.86
Retrospective cross-validation of simplified predictive index for renal replacement therapy after cardiac surgery. Interact Cardiovasc Thorac Surg (2008) 0.84
Use of bioresorbable vascular scaffolds in patients with stable angina and acute coronary syndromes. Polish National Registry. Kardiol Pol (2014) 0.83
Prognostic significance of hyperuricemia in patients with different types of renal dysfunction and acute myocardial infarction treated with percutaneous coronary intervention. Nephron Clin Pract (2010) 0.83
Effect of type of atrial fibrillation on prognosis in acute myocardial infarction treated invasively. Am J Cardiol (2012) 0.83
Comparison of modification of diet in renal disease and chronic kidney disease epidemiology collaboration formulas in predicting long-term outcomes in patients undergoing stent implantation due to stable coronary artery disease. Clin Res Cardiol (2014) 0.83
Prognosis in diabetic patients with acute myocardial infarction treated invasively is related to renal function. Med Sci Monit (2010) 0.82
Comparison of results of percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction during routine working hours or off-hours. Kardiol Pol (2007) 0.82
Serum concentrations of interleukin-4 and interferon-gamma in relation to severe left ventricular dysfunction in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart Vessels (2010) 0.82
Progression of coronary artery atherosclerosis after acute myocardial infarction: an angiographic study. J Invasive Cardiol (2010) 0.81
Comparison of invasive and non-invasive treatment strategies in older patients with acute myocardial infarction complicated by cardiogenic shock (from the Polish Registry of Acute Coronary Syndromes - PL-ACS). Am J Cardiol (2011) 0.81
Coronary sinus stenting for the stabilization of left ventricular lead during resynchronization therapy. Europace (2006) 0.80
Dedicated paclitaxel-eluting bifurcation stent BiOSS® (bifurcation optimisation stent system): 12-month results from a prospective registry of consecutive all-comers population. EuroIntervention (2012) 0.80
[Madelung disease--case report]. Pol Arch Med Wewn (2006) 0.79
[Effect of elevated bilirubin levels on the long-term outcome in patients with chronic heart failure due to hypertension]. Pol Arch Med Wewn (2007) 0.79
Does glucose level at hospital discharge predict one-year mortality in patients with diabetes mellitus treated with percutaneous coronary intervention for ST-segment elevation myocardial infarction? Kardiol Pol (2008) 0.79
The impact of unsuccessful percutaneous coronary intervention on short- and long-term prognosis in STEMI and NSTEMI. Catheter Cardiovasc Interv (2011) 0.79
Effect of omeprazole on the concentration of interleukin-6 and transforming growth factor-β1 in patients receiving dual antiplatelet therapy after percutaneous coronary intervention. Eur Cytokine Netw (2010) 0.78
Circadian and sex-dependent QT dynamics. Pacing Clin Electrophysiol (2005) 0.78
Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms (from a prospective national observational study [PL-ACS]). Am J Cardiol (2010) 0.78
Therapeutic window for calcium-channel blockers in the management of dilated cardiomyopathy: a prospective, two-centre study on non-advanced disease. Cardiology (2010) 0.78
Lipomatous hypertrophy of the interatrial septum: a rare cause of right ventricular impairment. J Card Surg (2009) 0.78
ST-segment elevation myocardial infarction in women with type 2 diabetes. Diabetes Care (2013) 0.78
Platelet-to-lymphocyte ratio is a marker of poor prognosis in patients with diabetes mellitus and ST-elevation myocardial infarction. Biomark Med (2015) 0.78
Effects of renal sympathetic denervation on blood pressure and glycaemic control in patients with true resistant hypertension: results of Polish Renal Denervation Registry (RDN-POL Registry). Kardiol Pol (2016) 0.77
Risk Prediction in Acute Myocardial Infarction. J Am Coll Cardiol (2016) 0.77
Different types of renal dysfunction in patients with acute myocardial infarction treated with percutaneous coronary intervention. J Interv Cardiol (2007) 0.77
Serum interleukin-6 concentration reflects the extent of asymptomatic left ventricular dysfunction and predicts progression to heart failure in patients with stable coronary artery disease. Cytokine (2011) 0.77
Pulmonary embolism and intra-aortic thrombosis in essential thrombocythaemia. Br J Haematol (2012) 0.77
Serum interleukin-6 concentration predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Eur Cytokine Netw (2010) 0.77
Long-term prognosis and risk factors for cardiac adverse events in patients with chronic systolic heart failure due to hypertension. Pol Arch Med Wewn (2008) 0.77
Mortality of patients with ST-segment elevation myocardial infarction and cardiogenic shock treated by PCI is correlated to the infarct-related artery--results from the PL-ACS Registry. Int J Cardiol (2011) 0.77
No predictive value of serum interleukin-6 and transforming growth factor-beta1 in identifying patients with a first restenosis, recurrent restenosis or a history of restenosis. Eur Cytokine Netw (2009) 0.76
Statins: the good, the bad and the ugly. CMAJ (2012) 0.75